unknown
Stage
About
Aprovix develops Qvintip®, a clinically validated, single-use self-sampling device for HPV detection designed to increase access to cervical cancer screening by enabling at-home HPV testing with clinical accuracy comparable to clinician-collected samples.
Explore Aprovix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.